腹部放射学会肝细胞癌诊断疾病聚焦小组关于LI-RADS v2018用于CT和MRI的白皮书
本文为腹部放射学会肝细胞癌诊断疾病聚焦小组关于LI-RADS v2018用于CT和MRI的白皮书。2018年美国肝病研究学会将LI-RADS整合入其肝细胞癌影像诊断临床实践指南,需对LI-RADS v2017做小幅修改而形成v2018。文章概述v2018关键变更,包括取消10-19 mm观察灶归类为LR-5前需在既往监测超声上可见的要求,以及采用器官获取与移植网络对阈值生长的定义(肿块在≤6个月内增大≥50%)。
要点
- LI-RADS v2018取消10-19 mm观察灶归为LR-5前需在既往监测超声上可见的要求。
- LI-RADS v2018采用器官获取与移植网络阈值生长定义:肿块≤6个月内增大≥50%。
- LI-RADS v2018命名变更:LR-5不再使用-us和-g限定词。
核心结论
- LI-RADS v2018对LI-RADS v2017做小幅修改,以与美国肝病研究学会肝细胞癌影像诊断临床实践指南协调一致。
研究设计与样本
- 本文为腹部放射学会肝细胞癌诊断疾病聚焦小组关于LI-RADS v2018用于CT和MRI的白皮书。
- 文章概述LI-RADS v2018关键变更、诊断算法与标准、技术建议及管理建议。
诊断标准与关键数值
- 10-19 mm观察灶具有非环状动脉期高增强和非周边「廓清」时,LI-RADS v2018取消了归类为LR-5前需在既往监测超声上可见的要求。
- LI-RADS v2018采用器官获取与移植网络阈值生长定义:肿块在≤6个月内增大≥50%。
- LI-RADS v2018命名变更:移除-us和-g作为LR-5限定词。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The Liver Imaging and Reporting Data System (LI-RADS) is a comprehensive system for standardizing the terminology, technique, interpretation, reporting, and data collection of liver imaging with the overarching goal of improving communication, clinical care, education, and research relating to patients at risk for or diagnosed with hepatocellular carcinoma (HCC). In 2018, the American Association for the Study of Liver Diseases (AASLD) integrated LI-RADS into its clinical practice guidance for the imaging-based diagnosis of HCC. The harmonization between the AASLD and LI-RADS diagnostic imaging criteria required minor modifications to the recently released LI-RADS v2017 guidelines, necessitating a LI-RADS v2018 update. This article provides an overview of the key changes included in LI-RADS v2018 as well as a look at the LI-RADS v2018 diagnostic algorithm and criteria, technical recommendations, and management suggestions. Substantive changes in LI-RADS v2018 are the removal of the requirement for visibility on antecedent surveillance ultrasound for LI-RADS 5 (LR-5) categorization of 10-19 mm observations with nonrim arterial phase hyper-enhancement and nonperipheral "washout", and adoption of the Organ Procurement and Transplantation Network definition of threshold growth (≥ 50% size increase of a mass in ≤ 6 months). Nomenclatural changes in LI-RADS v2018 are the removal of -us and -g as LR-5 qualifiers.
引用
- Elsayes KM, Kielar AZ, Elmohr MM, et al. White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI. Abdom Radiol (NY). 2018. PMID: 30155697. doi:10.1007/s00261-018-1744-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。